Tg Therapeutics Inc (TGTX) Cost of Revenue & History | Stock Alarm

Demo Sign up Log In

Tg Therapeutics Inc · Cost of Revenue

TGTX Cost of Revenue

Latest reported$141.00Mperiod endingJun 30, 2026

TGTX Cost of Revenue ($0.00 → $141.00M)

Annual cost of revenue

High-resolution chart · PNG

TGTX cost of revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Tg Therapeutics Inc Cost of Revenue — Annual fiscal periods (USD)
Period ending	Cost of Revenue (USD)
Dec 31, 2025	100,714,000
Dec 31, 2024	38,486,000
Dec 31, 2023	14,131,000
Dec 31, 2022	265,000
Dec 31, 2021	790,000
Dec 31, 2020	0
Dec 31, 2019	0
Dec 31, 2018	88,000
Dec 31, 2017	82,355
Dec 31, 2016	62,960
Dec 31, 2015	0
Dec 31, 2014	0
Dec 31, 2013	0
Dec 31, 2012	0
Dec 31, 2011	0
Dec 31, 2010	0
Dec 31, 2009	0
Dec 31, 2008	0
Dec 31, 2007	0
Dec 31, 2006	0
Dec 31, 2005	0
Dec 31, 2004	0
Dec 31, 2003	0
Dec 31, 2002	0
Dec 31, 2001	2,082,568
Dec 31, 2000	4,059,335
Dec 31, 1999	800,000
Dec 31, 1998	-200,000
Dec 31, 1997	-100,000
Dec 31, 1996	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.